Citation Information :
Sonkusle S, Pattanashetti JI, Kalburgi NB, Patil KA, Singh V. Comparative Evaluation of Topical Application of Boswellia Serrata Gel with Chlorhexidine Gel in Management of Gingivitis: A Clinical Study. World J Dent 2022; 13 (6):641-646.
Aim: To evaluate and compare the efficacy of the topical application of Boswellia serrata gel and chlorhexidine gluconate gel in depletion of gingival inflammation and plaque in study participants diagnosed with plaque-induced gingivitis.
Materials and methods: A total of 60 study participants diagnosed with chronic gingivitis in the age-group 18–40 years signed up for the research and were categorized into three equal groups. Group I: scaling + Boswellia serrata gel, group II: Scaling + Chlorhexidine gluconate gel, group III: scaling + placebo gel. A detailed case history including Gingival Index (Loe and Silness, 1963), Plaque Index (Silness and Loe, 1964), and Sulcus Bleeding Index (Muhlemann & Son, 1971) was recorded in their first visit which were reassessed after 14 days (second visit) and 21 days (third visit) and comparison was made with the baseline data.
Results: The mean scores for Plaque Index, Gingival Index, and Sulcus Bleeding Index were significantly decreased during 2nd and 3rd visit after 14 and 21 days, respectively when compared with baseline scores. No significant difference was recorded between group I and group II (test groups) whereas there was significant difference between the test groups and group III (control group).
Conclusion: Both Boswellia serrata gel and chlorhexidine gluconate gel were similar in action when used for topical application along with scaling and polishing in the management of chronic gingivitis study participants.
Clinical significance: Boswellia serrata gel can be used as an adjunct to scaling and root planing as a long-term intervention due to its low cost availability and better tolerance when compared to the widespread side effects of chlorhexidine.
Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:177–187. DOI: 10.1902/jop.1918.104.22.168
Theilade E, Wright WH, Jensen SB, et al. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. J Periodontal Res 1966;1:1–13. DOI: 10.1111/j.1600-0765.1966.tb01842.x
Cobb CM. Non-surgical pocket therapy: mechanical. Ann Periodontol 1996;1(1):443–490. DOI: 10.1902/annals.1922.214.171.1243
Mizrahi B, Shapira L, Domb AJ, et al. Citrus oil and MgCl2 as antibacterial and anti-inflammatory agents. J Periodontol 2006;77(6):963–968. DOI: 10.1902/jop.2006.050278
Singh V, Pathak AK, Pal M, et al. Comparative evaluation of topical application of turmeric gel and 0.2% chlorhexidine gluconate gel in prevention of gingivitis. Natl J Maxillofac Surg 2015;6(1):67–71. DOI: 10.4103/0975-5950.168238
Kathpalia H, Shreya KK. Topical nanoemmigel formulation of Boswellia serrata. Indian J Pharm Sci 2018:80(2):261–267. DOI: 10.4172/pharmaceutical-sciences.1000353
Siddiqui MZ. Boswellia serrata, A potential anti-inflammatory agent: an overview. Indian J Pharm Sci 2011; 73(3):255–261. DOI: 10.4103/0250-474X.93507
Lemenith M, Teketay D. Frankincense and Myrhh resources of Ethiopia: II. Medicinal and industrial uses. Ethiop J Sci 2003;26(2): 161–172. DOI: 10.4314/sinet.v26i2.18213
Khoshbakht Z, Khashabi E, Khodaie L, et al. Evaluation of herbal mouthwashes containing Zataria Multiflora and Boiss, Frankincense and combination therapy on patients with gingivitis: a double-blind, randomized, controlled, clinical trial. Galen Med J 2019;8:e1366. DOI: 10.31661/gmj.v8i0.1366
Samani MK, Mahmoodian H, Moghadamnia AA, et al. The effect of Frankiscense in the treatment of moderate plaque-induced gingivitis: a double blinded randomized clinical trial. Daru 2011;19(4):288–294.
Farjana HN, Chandrasekaran SC, Gita B. Effect of oral curcuma gel in gingivitis management. J Clin Diagn Res 2014;8(12):ZC08–ZC10. DOI: 10.7860/JCDR/2014/8784.5235
Sharma RA, Verma KC. Studies on gum obtained from Boswellia serrata Roxb. Indian Drugs 1980;17:225–227.
Ammon HP. Salai guggul-Boswellia serrata from a herbal medicine to a specific inhibitor of leukotriene biosynthesis. Phytomedicine 1996;3(1):67–70. DOI: 10.1016/S0944-7113(96)80012-2
Chande N, McDonald JW, MacDonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2017;(1):CD003575. DOI: 10.1002/14651858.cd003575.pub2
Raja AF, Ali F, Khan IA, et al. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes 2011;4:406. DOI: 10.1186/1756-0500-4-406
Alluri VK, Kundimi S, Sengupta K, et al. An inflammatory composition of Boswellia serrata resin extracts alleviates pain and protects cartilage in Monoiodoacetate-induced Osteoarthritis in rats. Evid Based Complement Alternat Med 2020;2020:7381625. DOI: 10.1155/2020/7381625